IDEC-Y2B8

IDEC-Y2B8
An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Also called yttrium Y90 ibritumomab tiuxetan.

English dictionary of cancer terms . 2015.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • List of oncology-related terms — This is a list of terms related to oncology. The original source for this list was the U.S. National Cancer Institute s public domain Dictionary of Cancer Terms . NOTOC 1 * 10 propargyl 10 deazaaminopterin * 12 O tetradecanoylphorbol 13 acetate * …   Wikipedia

  • Yttrium Y 90 ibritumomab tiuxetan — Yttrium Y 90 ibritumomab tiuxetan, also known as IDEC Y2B8 monoclonal antibody, is an anticancer drug. It is a combination of the radioisotope yttrium 90 and a monoclonal antibody, a produced substance that can locate and bind to cancer cells.… …   Wikipedia

  • yttrium Y90 ibritumomab tiuxetan — An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium 90). Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Also called IDEC Y2B8 …   English dictionary of cancer terms

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”